FRTY - ETF AI Analysis
Top Page
Alger Mid Cap 40 ETF (FRTY)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Year-to-Date Results
The fund has delivered solid gains so far this year, showing that its strategy has recently been working well for investors.
High-Performing Top Holdings
Several of the largest positions, such as Twist Bioscience, Cloudflare, Comfort Systems, Modine, nLIGHT, and Nebius Group, have shown strong performance, helping drive the ETF’s overall returns.
Diversified Sector Mix Within Mid Caps
Holdings spread across technology, industrials, health care, and several other sectors help reduce the impact if any one industry runs into trouble.
Negative Factors
Concentrated Portfolio in Only 40 Stocks
With a relatively small number of holdings, each stock has a bigger impact on results, which can increase volatility for investors.
Heavy U.S.-Only Exposure
Almost all assets are invested in U.S. companies, offering little geographic diversification if the U.S. market weakens.
Mixed Performance Among Top Holdings
Some key positions like Liberty Media Liberty Formula One, Repligen, Heico, and Axon Enterprise have shown weaker recent performance, which can offset gains from stronger names.
FRTY vs. SPDR S&P 500 ETF (SPY)
AUM153.26M
RegionNorth America
Expense Ratio0.60%
Beta1.32
IssuerAlger
Inception DateFeb 26, 2021
Dividend Yield0.17%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume20,316
30 Day Avg. Volume20,528
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
27.47Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering39
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FRTY Summary
The Alger Mid Cap 40 ETF (FRTY) is a fund that invests in about 40 medium‑sized U.S. companies that are focused on growth. It doesn’t track a set index, but instead follows a mid‑cap growth theme, choosing firms in areas like technology, industrials, and health care. Well‑known names in the fund include Cloudflare and Axon Enterprise. Someone might invest in FRTY to seek higher growth than large, slower‑moving companies and to diversify beyond big blue‑chip stocks. A key risk is that mid‑cap growth stocks can be more volatile, so the ETF’s value can rise and fall sharply with the market.
How much will it cost me?The Alger Mid Cap 40 ETF (Ticker: FRTY) has an expense ratio of 0.6%, meaning you’ll pay $6 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on a curated portfolio of 40 mid-cap growth stocks, which requires more research and management compared to passively managed ETFs.
What would affect this ETF?The Alger Mid Cap 40 ETF (FRTY) could benefit from continued innovation and growth in sectors like technology and communication services, which make up a significant portion of its holdings. However, it may face challenges if economic conditions worsen, as mid-cap companies are often more sensitive to market volatility and higher interest rates could impact growth-focused stocks. Regulatory changes or sector-specific disruptions in industries like healthcare or consumer cyclical could also influence performance.
FRTY Top 10 Holdings
FRTY is leaning hard into U.S. mid-cap growth, with a clear tilt toward innovative tech and health care names. Cloudflare and Comfort Systems have been steady climbers, helping power the fund’s recent momentum, while nLIGHT’s sharp upswing adds extra fuel from the industrial-tech side. On the flip side, Nebius Group and Twist Bioscience have been more of a headwind, with choppy performance that dulls some of the shine. Overall, the ETF is concentrated in a handful of rising, high-growth stories, making it a focused but somewhat volatile ride.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Twist Bioscience | 5.75% | $8.60M | $7.25B | 351.97% | 43 Neutral | |
| Liberty Media Liberty Formula One | 4.71% | $7.04M | $25.55B | 7.94% | 66 Neutral | |
| Repligen | 3.99% | $5.97M | $9.25B | 45.84% | 68 Neutral | |
| Heico Cp Cl A | 3.55% | $5.32M | $42.81B | 8.02% | 79 Outperform | |
| Cloudflare | 3.48% | $5.21M | $107.01B | 54.39% | 61 Neutral | |
| RBC Bearings | 3.16% | $4.73M | $17.96B | 40.23% | 77 Outperform | |
| Snowflake | 3.16% | $4.73M | $114.55B | 74.50% | 54 Neutral | |
| Comfort Systems | 3.13% | $4.68M | $59.64B | 141.57% | 80 Outperform | |
| Arrowhead Pharmaceuticals | 3.10% | $4.64M | $12.38B | 413.25% | 57 Neutral | |
| Guardant Health | 3.10% | $4.63M | $22.61B | 205.13% | 61 Neutral |
FRTY Technical Analysis
Positive
―
Price Trends
23.06
Positive
22.08
Positive
21.58
Positive
Market Momentum
0.17
Negative
58.83
Neutral
94.84
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FRTY, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 22.62, equal to the 50-day MA of 23.06, and equal to the 200-day MA of 21.58, indicating a bullish trend. The MACD of 0.17 indicates Negative momentum. The RSI at 58.83 is Neutral, neither overbought nor oversold. The STOCH value of 94.84 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FRTY.
FRTY Peer Comparison
Comparison Results
Performance Comparison
FRTY
Alger Mid Cap 40 ETF
23.61
3.44
17.06%
AVMV
Avantis U.S. Mid Cap Value ETF
―
―
―
AVMC
Avantis U.S. Mid Cap Equity ETF
―
―
―
GLRY
Inspire Faithward Mid Cap Momentum ESG ETF
―
―
―
TMFM
Motley Fool Mid-Cap Growth ETF
―
―
―
MID.ETF
American Century Mid Cap Growth Impact ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents